U.S. patent application number 10/669596 was filed with the patent office on 2004-03-25 for biomolecular wearable apparatus.
Invention is credited to Schmidt, David.
Application Number | 20040057983 10/669596 |
Document ID | / |
Family ID | 31998188 |
Filed Date | 2004-03-25 |
United States Patent
Application |
20040057983 |
Kind Code |
A1 |
Schmidt, David |
March 25, 2004 |
Biomolecular wearable apparatus
Abstract
This invention relates to an apparatus that regulates
thermodynamic energy-flow within a human body for producing
beneficial effects such as, for example, improvement in strength,
improvement in stamina, pain relief, etc. According to one
embodiment, the invention provides a wearable apparatus that may
include biomolecular components for building-up of a thermomagnetic
energy within the human body. According to another embodiment, the
invention provides a wearable apparatus that may include
biomolecular components for dilution of a thermomagnetic energy
within the human body. According to yet another embodiment, the
invention provides a wearable apparatus that may include
biomolecular components having orthomolecular and/or
non-orthomolecular organic materials which are capable of
thermomagnetic levororotary action and/or thermomagnetic
dextrorotatory action.
Inventors: |
Schmidt, David; (Buford,
GA) |
Correspondence
Address: |
MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC
12010 SUNSET HILLS ROAD
SUITE 900
RESTON
VA
20190
US
|
Family ID: |
31998188 |
Appl. No.: |
10/669596 |
Filed: |
September 25, 2003 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
60413617 |
Sep 25, 2002 |
|
|
|
Current U.S.
Class: |
424/443 |
Current CPC
Class: |
A61K 9/7084 20130101;
A61K 9/7023 20130101; A61K 31/205 20130101; A61K 31/047 20130101;
A61K 31/198 20130101; A61K 31/194 20130101; A61K 31/7004 20130101;
A61K 31/716 20130101; A61M 37/00 20130101; A61K 31/185
20130101 |
Class at
Publication: |
424/443 |
International
Class: |
A61K 009/70 |
Claims
What is claimed is:
1. An apparatus for application to a subject's body to provide a
beneficial biological effect for the subject, the apparatus
comprising: at least one organic material including a Left-Handed
molecule; at least one substrate for said at least one organic
material; and at least one enclosure for said at least one organic
material and said at least one substrate.
2. An apparatus for application to a subject's body to provide a
beneficial biological effect for the subject, the apparatus
comprising: at least one organic material including a Right-Handed
molecule; at least one substrate for said at least one organic
material; and at least one enclosure for said at least one organic
material and said at least one substrate.
3. The apparatus of claim 1, comprising a plurality of Left-Handed
molecules.
4. The apparatus of claim 2, comprising a plurality of Right-Handed
molecules.
5. The apparatus of claim 1, wherein said Left-Handed molecule is
capable of causing the beneficial biological effect by interacting
with a thermomagnetic energy-flow within the human body.
6. The apparatus of claim 1, wherein said Left-Handed molecule is
an amino acid, wherein said amino acid is selected from a group
consisting of L-Alanine, L-Arginine, L-Aspargine, L-Aspartic Acid,
L-Carnitine, Acetyl-L-Carnitine, L-Camitine L-Tartrate, L-Camitine
Magnesium Citrate, L-Citrulline, L-Cysteine, L-Cystine, L-GABA,
L-Glutamic Acid, L-Glutamine, Glutathione Peroxidase, L-Glycine,
L-Histidine, Hydroxyglutamic Acid, Hydroxyproline, L-Isoleucine,
L-Leucine, Norleucine, L-Lysine, L-Methionine, L-Omithine,
L-Valine, L-Phenylalanine, L-Proline, L-Serine, L-Taurine,
L-Threonine, L-Tryptophan, and L-Tyrosine.
7. The apparatus of claim 2, wherein said Right-Handed molecule is
capable of causing the beneficial effect by interacting with a
thermomagnetic energy-flow within the human body.
8. The apparatus of claim 2, wherein said Right-Handed molecule is
a D-form of an amino acid, wherein said amino acid is selected from
a group consisting of D-Alanine, D-Arginine, D-Aspargine,
D-Aspartic Acid, D-Carnitine, Acetyl-D-Carnitine, D-Camitine
D-Tartrate, D-Camitine Magnesium Citrate, D-Citrulline, D-Cysteine,
D-Cystine, D-GABA, D-Glutamic Acid, D-Glutamine, D-Glutathione
Peroxidase, D-Glycine, D-Histidine, D-Hydroxyglutamic Acid,
D-Hydroxyproline, D-Soleucine, D-Leucine, D-Norleucine, D-Lysine,
D-Metbionine, D-Ornithine, D-Valine, D-Phenylalanine, D-Proline,
D-Serine, D-Taurine, D-Threonine, D-Tryptophan, and D-Tyrosine.
9. The apparatus of claim 2, wherein said Right-Handed molecule is
a sugar, wherein the sugar is dextrin, dextrose, fructose,
galactose, glucose, glycogen, inositol, invert sugar, lactose,
levulose, maltose, molasses, sucrose, or xylose.
10. The apparatus of claim 1, wherein the Left-Handed molecule is
an amino acid, wherein said amino acid is selected from a group
consisting of L-Arginine, L-Camitine, Acetyl-L-Carnitine,
L-Carnitine L-Tartrate, L-Carnitine Magnesium Citrate, L-Glutamine,
L-Methionine, L-Ornithine, and L-Taurine.
11. The apparatus of claim 1, wherein the Left-Handed molecule is
an amino acid, wherein said amino acid is selected from a group
consisting of L-Carnitine, Acetyl-L-Carnitine, L-Camitine
L-Tartrate, and L-Carnitine Magnesium Citrate.
12. The apparatus of claim 2, wherein the Right-Handed molecule is
a sugar, wherein the sugar is in a form of high fructose corn
syrup, honey, molasses or sugar cane.
13. The apparatus of claim 2, wherein the Right-Handed molecule is
associated with one or more of components including honey and
molasses.
14. The apparatus of claim 1, wherein said at least one substrate
is polyester or cotton.
15. The apparatus of claim 2, wherein said at least one substrate
is polyester or cotton.
16. The apparatus of claim 1, wherein said at least one enclosure
is made of a plastic film, wherein the plastic film is selected
from a group consisting of polyethylene, polypropylene, ABS,
plexiglass, lexan, light polarizing film, and linear low density
film.
17. The apparatus of claim 2, wherein said at least one enclosure
is made of a plastic film, wherein the plastic film is selected
from a group consisting of polyethylene, polypropylene, ABS,
plexiglass, lexan, light polarizing film, and linear low density
film.
18. The apparatus of claim 1, wherein said at least one enclosure
is made of at least one of a light polarizing film and a linear low
density film.
19. The apparatus of claim 2, wherein said at least one enclosure
is made of at least one of a light polarizing film and a linear low
density film.
20. The apparatus of claim 1, further comprising one or more
adhesive portions so as to attach said apparatus on a skin surface
of the subject.
21. The apparatus of claim 2, further comprising one or more
adhesive portions so as to attach said apparatus on a skin surface
of the subject.
22. The apparatus of claim 20, wherein said one or more adhesive
portions includes a medical grade adhesive.
23. The apparatus of claim 21, wherein said one or more adhesive
portions includes a medical grade adhesive.
24. The apparatus of claim 20, wherein said apparatus can be placed
in a predetermined location of a human body.
25. The apparatus of claim 21, wherein said apparatus can be placed
in a predetermined location of a human body.
26. The apparatus of claim 1, wherein said apparatus is embodied in
a bracelet.
27. The apparatus of claim 2, wherein said apparatus is embodied in
a bracelet.
28. The apparatus of claim 1, wherein said apparatus is embodied in
a necklace.
29. The apparatus of claim 2, wherein said apparatus is embodied in
a necklace.
30. The apparatus of claim 1, wherein said apparatus is embodied in
a watch.
31. The apparatus of claim 2, wherein said apparatus is embodied in
a watch.
32. The apparatus of claim 1, wherein said apparatus is embodied in
a pendant.
33. The apparatus of claim 2, wherein said apparatus is embodied in
a pendant.
34. The apparatus of claim 1, wherein the apparatus further
comprising one or more additives for said at least one organic
material, wherein said one or more additives are selected from a
group consisting of Glycerin, d-calcium pantothenate, sorbitol,
propylparaben, potassium sorbate, methylparaben, and Colloidal
Gold.
35. The apparatus of claim 2, wherein the apparatus further
comprising one or more additives for said at least one organic
material, wherein said one or more additives are selected from a
group consisting of Glycerin, d-calcium pantothenate, sorbitol,
propylparaben, potassium sorbate, methylparaben, and Colloidal
Gold.
36. The apparatus of claim 1, further comprising one or more
patches, wherein said patch(s) is (are) constructed in layers, said
layers including a plastic film or a light polarizing film as an
enclosure, a polyester fabric as a substrate, Water, L-Camitine,
Glycerin, d-calcium pantothenate, sorbitol, propylparaben,
potassium sorbate, and methylparaben.
37. The apparatus of claim 2, further comprising one or more
patches, wherein said patch(s) is (are) constructed in layers, said
layers including a plastic film or a light polarizing film as an
enclosure, a polyester fabric as a substrate, Water, L-Camitine,
Glycerin, d-calcium pantothenate, sorbitol, propylparaben,
potassium sorbate, and methylparaben.
38. The apparatus of claim 1, further comprising one or more
patches, wherein said patch(s) is (are) constructed in layers, said
layers including a plastic film or a light polarizing film as an
enclosure, a polyester fabric as a substrate, honey, and
molasses.
39. The apparatus of claim 2, further comprising one or more
patches, wherein said patch(s) is (are) constructed in layers, said
layers including a plastic film or a light polarizing film as an
enclosure, a polyester fabric as a substrate, honey, and
molasses.
40. A non-transdermal patch apparatus for application to a skin
surface on a human subject which causes a beneficial biological
effect in the subject's body comprising: at least one organic
material including a Left-Handed molecule; at least one substrate
for said at least one organic material; and at least one enclosure
for said at least one organic material and said at least one
substrate.
41. A non-transdermal patch apparatus for application to a skin
surface on a human subject which causes a beneficial biological
effect in the subject's body comprising: at least one organic
material including a Right-Handed molecule; at least one substrate
for said at least one organic material; and at least one enclosure
for said at least one organic material and said at least one
substrate.
42. The apparatus of claim 1, wherein the beneficial biological
effect is an improvement in the subject's stamina.
43. The apparatus of claim 2, wherein the beneficial biological
effect is an improvement in the subject's stamina.
44. The apparatus of claim 40, wherein the beneficial biological
effect is an improvement in the subject's stamina.
45. The apparatus of claim 41, wherein the beneficial biological
effect is an improvement in the subject's stamina.
46. The apparatus of claim 1, wherein the beneficial biological
effect is an improvement in the subject's strength endurance.
47. The apparatus of claim 2, wherein the beneficial biological
effect is an improvement in the subject's strength endurance.
48. The apparatus of claim 40, wherein the beneficial biological
effect is an improvement in the subject's strength endurance.
49. The apparatus of claim 41, wherein the beneficial biological
effect is an improvement in the subject's strength endurance.
50. The apparatus of claim 1, wherein the beneficial biological
effect is an improvement in physical strength for the subject.
51. The apparatus of claim 2, wherein the beneficial biological
effect is an improvement in physical strength for the subject.
52. The apparatus of claim 40, wherein the beneficial biological
effect is an improvement in physical strength for the subject.
53. The apparatus of claim 41, wherein the beneficial biological
effect is an improvement in physical strength for the subject.
54. The apparatus of claim 1, wherein the beneficial biological
effect is relief from pain experienced by the subject.
55. The apparatus of claim 2, wherein the beneficial biological
effect is relief from pain experienced by the subject.
56. The apparatus of claim 40, wherein the beneficial biological
effect is relief from pain experienced by the subject.
57. The apparatus of claim 41, wherein the beneficial biological
effect is relief from pain experienced by the subject.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
[0001] This application claims priority from U.S. provisional
patent application serial No. 60/413,617, filed on Sep. 25, 2002,
which is incorporated by reference in its entirety.
FIELD OF THE INVENTION
[0002] This invention relates generally to a biomolecular wearable
apparatus regulating energy-flow, and more particularly to a
biomolecular wearable apparatus regulating thermomagnetic energy
flow within human body for producing beneficial effects including
an improvement in stamina and a relief from a pain.
BACKGROUND OF THE INVENTION
[0003] Jewelries including ring, necklace, bracelets, and pendants
are typically used for decorative purpose. However, there is a
segment of the jewelry market that concerns itself for a purpose
other than decorative. Examples of jewelries that are designed for
the purpose other than decorative include copper bracelets and
magnetic jewelries.
[0004] Copper bracelet is believed to perform functions of
relieving pain and helping to alleviate symptoms of arthritis for a
user. A mode of operation for these functions has been proposed as
mobility of copper ions from the copper bracelet through the user's
skin and into the user's blood stream. If the mobility of copper
ions is the mode of operation of a copper bracelet, then an
individual or a user could not obtain immediate relief from pain,
etc., due to a long period of time required for this mode of
operation to become effective. Accordingly, a drawback of existing
systems with respect to a copper bracelet is that the therapeutic
response--if any--takes place over a relatively long period of
time. Another drawback of the existing systems is that the copper
bracelets have a limited and narrow field of use.
[0005] Various types of magnetic jewelries are believed to perform
functions of relieving pain and improving circulation. Clinical
studies performed with magnetic jewelries indicated that there is
an effect going on other than a placebo effect. An effect of a
magnet on a human body could be due, in part, to the fact that
human blood contains iron. In one theory, the iron in the blood
causes the blood to be attracted to a part of the body in which the
magnet is worn, resulting in improvement in circulation. However,
there are biophysicists who question the efficacy of a magnetic
jewelry. For example, it is well known that the DNA contains
Hydrogen bonds. Because a magnet is polar in nature, a back emf
from the magnet to the Hydrogen bonds may be possible. This might
cause the Hydrogen to spin in opposition to what is normal and
disassemble the DNA of that cell. In any case, long term studies of
magnets as they apply to humans are needed. Another drawback of the
existing systems with respect to a magnetic jewelry, is that the
therapeutic response--if any--is limited and narrow with respect to
the field of use.
[0006] Therefore, with respect to jewelries that may be utilized
for the purpose of achieving a therapeutic effect, there is a need
for an alternative to the copper bracelet and the magnetic
jewelries that are found in the present market. Such alternative
may require a mode of operation that is different from the modes of
operation of the existing copper bracelet and magnetic jewelries.
In this regard, an examination of alternative modes of operation
for a passive therapeutic jewelry needs to be considered.
[0007] First, referring to eastern philosophies, and specifically
the Indian belief of a human CHAKRA SYSTEM, a representation of
what is referred to in eastern medicine and philosophy as the human
Chakra system is described. According to eastern philosophy, the
human Chakras are points in the body in which a vortex-like flow
reversal occurs, establishing a strong energy point in the human
body. Like acupuncture, the concept of a "Chakra" system in human
beings has not been embraced by conventional western medicine.
However, it is interesting to note that the Chakra points do
coincide with acupuncture points. Furthermore, the Chakra point of
the Heart (#4, Anahata/Anandakanda) has special relevance to the
invention disclosed here.
[0008] Referring now to publicly available HUMAN ACUPUNCTURE
CHARTS, a representation of various human acupuncture and
acupressure points are described. Unlike the "Chakra" concept,
acupuncture has had some acceptance in western medicine, although
this acceptance has only happened over a period of decades. As may
be seen in Acupuncture Charts, there is a strong Chi (energy) point
at the same point as the #4 Chakra. This is known as the Shanzhong
point, and is indicative of the primary energy flow point in the
human body. For further clarification, this point is located on the
anterior midline, at the level of the fourth intercostals space. An
additional point of interest is the Zhongji point, located 4 cun
below the umbilicus, and is indicative of the crossing point of the
ren channel. This is not to say that there are not additional
points of interest in the acupuncture system.
[0009] Referring now to the work of Davis and Rawls (Magnetism and
its effect on the living system by Albert Roy Davis and Walter C.
Rawls, April 1996, Acres USA Publications), a view has been
illustrated for actual electrical measurements made on the front
surfaces of a human body. These measurements were performed by
Albert Roy Davis and Walter Rawls at the Albert Roy Davis Research
Laboratory in Florida. The findings of these two researchers
indicate that the right side of the human body is positively
(electrically) charged and the left side of the human body is
negatively charged. These findings also indicate the average
voltages that were recorded at various locations of the human body.
It is worth noting that the vicinity of the #4 Chakra point shows
the highest voltage among all the points on the human body. This
would also coincide with the belief in the acupuncture system that
the Shanzhong point is the strongest Chi point in the human
body.
[0010] Referring again to Rawis and Davis (Magnetism and its effect
on the living system by Albert Roy Davis and Walter C. Rawls, April
1996, Acres USA Publications), a view has been illustrated for the
electromagnetic equators of the human body. Of interest with
respect to the invention disclosed here is the point in the center
of the chest, which Davis and Rawls state that according to their
findings, this point is where voltage change is noted, and at this
point there is zero voltage when measuring from the crotch to this
point. Again, this corresponds well with the Chakra system and the
acupuncture system.
[0011] In addition, the body of evidence supporting acupuncture has
reached the point of being irrefutable. This said, a conclusion may
be reached that in addition to blood flowing through the human
body, there is also an energy flow through the human body.
[0012] In order to understand the energy flow through the human
body, a phenomenon of a thermomagnetic field may need to be
considered. A thermomagnetic field may be obtained when a group of
dissimilar metals is arranged so as to form a coil, with each
dissimilar metal junction being alternately heated and cooled. To
illustrate this effect, reference is now made to the work of
Schroeder, with publicly titled documents (U.S. Pat. No. 5,393,350
and U.S. Pat. No. 5,597,976) entitled THERMOELECTRIC GENERATOR AND
MAGNETIC ENERGY STORAGE UNIT invented by Schroeder. In operation,
this device is capable of obtaining a low voltage, high current
within the ring structure resulting in a magnetic field of 10 to 20
tesla. The magnetic field produced is so strong that the ring
requires structural reinforcement with Keviar or the like. The
point made here is that this device produces a magnetic field in a
novel manner, a method that does not use an electrical input but
rather an input of heat.
[0013] Referring now to FIG. 1, a human body as illustrated relates
to temperature differential. As illustrated in FIG. 1, human beings
maintain a core temperature that is higher with respect to the
extremities of the hands and feet. This differential is well known
in the art and may be viewed in detail via infrared imaging
techniques well known to those of skilled in the art. Due to this
temperature differential as well as other factors, the conditions
necessary for the production of thermomagnetic fields within the
human body may be present. This phenomenon is scientifically
plausible when one considers temperature differential, the presence
of dissimilar metal components in the body such as Iron (blood) and
Copper (collagen, enzymes, etc.), and the manner in which the blood
flows via the circulatory system (flow reversals at extremities).
In eastern philosophy, the thermomagnetic field is referred to as
the "Aura", and is shown to extend several inches from the body.
This would be consistent with magnetism. Furthermore, Kirlian
photography technique records a field of energy emanating several
inches from humans and plants, again consistent with magnetic
fields.
[0014] If there is indeed a magnetic energy field that extends from
the surface of a human body, then it should be possible to
construct a passive apparatus that would be capable of interacting
with this field, and altering the properties of this field. As an
example, in acupuncture, a practitioner utilizes known techniques
to detect "blockages" to energy flows in the human body. When the
locations of these blockages are determined, then either needles or
pressure is applied to this point for the purpose of relieving and
removing the blockages. Accordingly, another drawback of the
existing systems is a lack of an apparatus that can be placed over
specific acupuncture points and that can interact with a humans'
energy field and promote energy flow and circulation in a similar
mode of operation to acupuncture but without needles or physical
contact.
[0015] When considering the flow of either fluids or energy, we now
consider vortex flows that consist of either centripetal or
centrifugal forces, and how these flows might be produced
passively. As will be recalled, a vortex may have an inward
spiraling flow (centripetal) or an outward spiraling flow
(centrifugal). In nature, the tornado is an example of a phenomena
that illustrates both flow types. Further, it is often stated that
an inward spiraling vortex is associated with a build-up of energy,
such as the destructive tip of the tornado, while an outward
spiraling vortex is associated with a dilution of energy.
[0016] Various chemical species in the human body and biochemical
materials may also need to be considered since they may play a role
in interacting with energy fields within the human body. To this
end, Left-Handed and Right-Handed molecules may need to be
considered. It is known that the Left-Handed group of molecules
known as amino acids are utilized in the body for the purpose of
building protein structures such as muscle tissue. This process of
the amino acid forming a "building block" for a larger protein
structure is generally recognized as being a solely chemical
process. However, if all naturally occurring amino acids are
considered Left-Handed (amino acids are isomers and demonstrate the
phenomena of optical chirality), and that light passing through an
amino acid will bend to the left, a thermomagnetic field in the
presence of an L-amino acid would orient itself to the left as
well. Accordingly, at the molecular level, in the process of the
amino acid being used to form a protein, the human thermomagnetic
field twists to the left in the presence of the L-amino acid,
causing the thermomagnetic field to spin clockwise (inward) which
creates a buildup of energy, with this energy assisting in the
formation of the new protein structure.
[0017] Similarly, some sugars such as sucrose may play a role in
the human body. Common table sugar is a right-handed molecule.
Thus, the human thermomagnetic field in the presence of sugar would
spin counter-clockwise thereby creating a centrifugal flow which
would lead to the dissipation of an energy field. This would at
first seem to be inconsistent with the role that sugar plays in the
body, which would be to create the basic building blocks of energy
units (ATP). However, if we examine the actual chemical process
that sugar is involved in, then we know that in order for sugar to
enter the ATP cycle, it must first be broken down. Accordingly, at
the molecular level, in the process of the sugar being broken down
so that it may be used for the creation of ATP, the human
thermomagnetic field twists to the right in the presence of the
sugar, causing the thermomagnetic field to spin counter-clockwise
(outward) which creates a dissipation of the structure, with this
energy assisting in the destruction of the sugar molecule.
[0018] If these effects are occurring within the human body, then
it should be possible to create a device that passively interacts
with the human body in such a way so as to promote the build-up or
flow of energy within the human body.
[0019] Therefore, another drawback of the existing system is a lack
of an apparatus and a method for regulating the energy-flow,
thereby producing a beneficial response within the human body.
[0020] These and other drawbacks also exist.
SUMMARY OF THE INVENTION
[0021] The invention overcomes these and other drawbacks.
[0022] In one embodiment, the invention provides an apparatus that
produces a beneficial effect when placed on a human body. In some
embodiments, the beneficial effect may include, for example,
strength increase, stamina increase, pain relief, etc.
[0023] In one embodiment, the invention provides an apparatus that
regulates thermomagnetic energy flow within a human body.
[0024] In one embodiment, the invention provides an apparatus that
produces a beneficial effect when placed on a human body, wherein
the apparatus regulates thermodynamic energy-flow within the human
body for producing the beneficial effect.
[0025] In one embodiment, the invention provides an apparatus that
includes biomolecular components for regulating thermomagnetic
energy flow within a human body. In one embodiment, the
biomolecular components may include molecules associated with
building-up of energy (e.g., thermomagnetic energy). In another
embodiment, the biomolecular components may include molecules
associated with dilution of energy (e.g., thermomagnetic energy).
In yet another embodiment, the biomolecular components may include
molecules associated with building-up of energy (e.g.,
thermomagnetic energy) and dilution of energy (e.g., thermomagnetic
energy). In a further embodiment, the biomolecular components may
include orthomolecular and/or non-orthomolecular organic materials
capable of thermomagnetic levororotary action and/or thermomagnetic
dextrorotatory action.
[0026] In one embodiment, the invention provides an apparatus
including biomolecular components associated with building-up of
energy, wherein the biomolecular components may include, for
example, but not limited to a Left-Handed molecule such as an amino
acid (e.g., L-Glutamine).
[0027] In one embodiment, the invention provides an apparatus
including biomolecular components associated with dilution of
energy, wherein the biomolecular components may include, for
example, but not limited to a Right-Handed molecule such as sugar,
D-Glutamic acid, etc.
[0028] In one embodiment, the invention provides an apparatus
including one or more substrates, for example, but not limited to a
polyester, cotton fabric sheet, etc., for biomolecular components
that regulate thermomagnetic energy flow within a human body.
[0029] In one embodiment, the invention provides an apparatus
including a sealed plastic enclosure, wherein the sealed plastic
enclosure may enclose biomolecular components regulating
thermomagnetic energy flow within a human body and one or more
substrates for the biomolecular components.
[0030] In one embodiment, the invention provides an apparatus that
includes a sealed plastic enclosure having biomolecular components
regulating thermomagnetic energy flow within a human body and one
or more substrates for the biomolecular components, wherein the
apparatus further includes one or more gem stones (e.g., Jade,
powdered jade, etc.) for decorative purpose.
[0031] In one embodiment, the invention provides one or more
physical structural settings for holding components of an
apparatus. In some embodiments, said one or more physical
structural settings may hold biomolecular components regulating
thermomagnetic energy flow within a human body, one or more
substrates for said biomolecular components, and one or more gem
stones (e.g., Jade, powdered jade, etc.) for decorative
purpose.
[0032] In one embodiment, the invention provides an apparatus that
produces a beneficial effect, for example improvement in
strength/stamina, when placed on a human body, wherein the
apparatus may comprise one or more of components including, for
example, Left-Handed molecules (e.g., L-Glutamine), one or more
substrates (e.g., a polyester, cotton fabric sheet, etc.) for said
Left-Handed molecules, a sealed enclosure (e.g., plastic film
enclosure) enclosing said Left-Handed molecules and said one or
more substrates, one or more gem stones or similar materials (e.g.,
jade, etc.).
[0033] In one embodiment, the invention provides an apparatus that
produces a beneficial effect, for example relief from a pain, when
placed on a human body, wherein the apparatus may comprise one or
more of components including, for example, Right-Handed molecules
(e.g., sucrose, D-Glutamic acid, etc.), one or more substrates
(e.g., a polyester, cotton fabric sheet, etc.) for said
Right-Handed molecules, a sealed enclosure (e.g., plastic film
enclosure) enclosing said Right-Handed molecules and said one or
more substrates, one or more gem stones or similar materials (e.g.,
jade, etc.).
[0034] In one embodiment, the invention provides an apparatus that
may be in one or more of a plurality of wearable objects such as
dermal patches, bracelets, pendants, support pads, shirts, socks,
foot inserts, etc.
[0035] In some embodiments, the invention provides a
non-transdermal patch having Left-Handed molecules for improving
strength/stamina for a user. According to the invention, the
non-transdermal patch having Left-Handed molecules may be
manufactured with the following specifications:
[0036] 500 mg of L-Glutamine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Glutamine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0037] In other embodiments, the invention provides a
non-transdermal patch having Right-Handed molecules for relieving
from a pain for a user. According to the invention, the
non-transdermal patch having Right-Handed molecules may be
manufactured with the following specifications: Honey in its raw
form (Sioux Honey) and unsulphured Molasses (Grandma Molasses) is
utilized as the patch ingredient. The ratio of Honey to Molasses is
3 lb. of honey by weight to 355 ml of Molasses. A Pellon 100%
polyester interfacing material is cut to a 1" diameter disk; GBC
Heat Laminating films (# 3000038 clear polyester substrate with
homopolymer adhesive) are cut to 1.69" in diameter. Two pieces of
the interfacing material are dipped in the Honey/Molasses solution
so as to saturate the fabric with the solution. The
honey/molasses-saturated fabric disks are then sandwiched and
placed between layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0038] In one embodiment, the invention provides a method for
fabricating an apparatus that produces a beneficial effect when
placed on a human body, wherein the apparatus regulates
thermomagnetic energy-flow within the human body for producing the
beneficial effect.
[0039] In one embodiment, the invention provides a method for
placing an apparatus on a human body or into a human body, wherein
the apparatus produces a beneficial effect when placed on the human
body or into the human body, wherein the apparatus regulates
thermomagnetic energy-flow within the human body for producing the
beneficial effect.
[0040] Other objects and features of the invention will become
apparent from the following detailed description considered in
connection with the accompanying drawings that disclose embodiments
of the invention. It should be understood, however, that the
drawings are designed for purposes of illustration only and not as
a definition of the limits of the invention.
BRIEF DESCRIPTIONS OF THE DRAWINGS
[0041] FIG. 1 illustrates temperature differential in a human
body.
[0042] FIG. 2A illustrates an example of an apparatus including a
single layer fabric substrate for retaining biomolecular
components, according to an embodiment of the invention.
[0043] FIG. 2B illustrates an example of a sealed apparatus
including a single layer fabric substrate for retaining
biomolecular components, according to an embodiment of the
invention.
[0044] FIG. 3A illustrates an example of an apparatus including a
multi-layer fabric substrate for retaining biomolecular components,
according to an embodiment of the invention.
[0045] FIG. 3B illustrates an example of a sealed apparatus
including a multi-layer fabric substrate for retaining biomolecular
components, according to an embodiment of the invention.
[0046] FIG. 4 illustrates an example of a patch including a
biomolecular apparatus that causes a beneficial effect within a
human body, according to an embodiment of the invention.
[0047] FIG. 5 illustrates an example of a bracelet including a
biomolecular apparatus that causes a beneficial effect within a
human body, according to an embodiment of the invention.
[0048] FIG. 6 illustrates an example of a ring including a
biomolecular apparatus that causes a beneficial effect within a
human body, according to an embodiment of the invention.
[0049] FIG. 7 illustrates an example of a watch including a
biomolecular apparatus that causes a beneficial effect within a
human body, according to an embodiment of the invention.
DETAILED DESCRIPTION OF THE INVENTION
[0050] According to one embodiment, the invention provides an
apparatus that produces a beneficial effect when placed on a human
body, wherein the apparatus regulates thermodynamic energy-flow
within the human body for producing the beneficial effect. In some
embodiments, the beneficial effect may include, for example,
strength increase, stamina increase, and pain relief.
[0051] According to another embodiment, the invention provides an
apparatus that may include biomolecular components for regulating
thermomagnetic energy flow within a human body. In one embodiment,
the biomolecular components may include molecules associated with
building-up of energy (e.g., thermomagnetic energy). In another
embodiment, the biomolecular components may include molecules
associated with dilution of energy (e.g., thermomagnetic energy).
In yet another embodiment, the biomolecular components may include
molecules associated with building-up of energy (e.g.,
thermomagnetic energy) and dilution of energy (e.g., thermomagnetic
energy). In a further embodiment, the biomolecular components may
include orthomolecular (e.g., naturally occurring organic
compounds) and/or non-orthomolecular organic materials capable of
thermomagnetic levororotary action and/or thermomagnetic
dextrorotatory action.
[0052] According to another embodiment, the invention provides an
apparatus that may include orthomolecular organic compounds (e.g.,
naturally occurring organic compounds) and or non-orthomolecular
organic compounds for inducing one or more beneficial effects such
as, for example, strength increase, stamina increase, pain relief,
etc.
[0053] Some of the orthomolecular and non-orthomolecular organic
compounds may be more fully described as complex organic structures
with asymmetric carbon atoms capable of either thermomagnetic
levorotatory action due to the proton pulling forces associated
with thermomagnetic fields or thermomagnetic dextrorotatory action
due to the proton pulling forces associated with thermomagnetic
fields. In both cases, according to one embodiment of the
invention, the orthomolecular and/or nonorthomolecular organic
materials utilized may be arranged parallel with respect to the
plane of thermomagnetic rotation.
[0054] According to another embodiment, the invention provides an
apparatus, wherein the apparatus functions on the basis of the
principle that the proton pulling forces associated with human
thermomagnetic fields are capable of interacting with passive
orthomolecular and or non-orthomolecular organic materials so long
as these materials are arranged parallel to the plane of rotation,
with this arrangement inducing electron flow due to well known and
long established electromotive principles.
[0055] It is known that hemoglobin is an Iron-containing pigment of
red blood cells. Its function is to carry Oxygen from the lungs to
other tissues. It is also known that collagen is a Copper
containing, fibrous insoluble protein in connective tissues,
including skin, bone, ligaments and cartilage. In addition, human
beings possess a natural temperature differential from the core to
the extremities.
[0056] In physics, the Seebeck effect describes a phenomena in
which when an apparatus consists of two metals (such as Iron and
Copper), with one metal at a higher temperature than the other, a
current flows in the apparatus. The Thomson thermoelectric effect
is the designation of the potential gradient along a conductor
which accompanies a temperature gradient.
[0057] The thermomagnetic phenomena arises in that the
thermoelectric and thermomagnetic power is measured by
electromotive force produced by the unit difference of temperature,
in this case the temperature differential from the core to the
extremities. In short, all of the conditions necessary for human
beings to produce thermomagnetic fields are present in humans.
[0058] According to another embodiment, the invention provides a
passive apparatus that includes orthomolecular and
non-orthomolecular organic compounds for improving one or more
beneficial effects (e.g., strength, stamina, human performance,
etc.) by interacting with a human thermomagnetic field. This
interaction may induce an increased electron flow within a human
body. In some embodiments, this interaction is not unlike the
effect that occurs in an electrical generator in which electricity
is produced from moving magnets or magnetic fields.
[0059] In humans, an increase in electron flow has numerous
demonstrable benefits with one being an immediate and measurable
increase in physical strength. This is not a chemically induced
increase in strength such as would be the case with anabolic
steroids, etc., but rather a phenomena in which existing muscle
mass is utilized more efficiently due to the increase in electron
flow.
[0060] To understand how this phenomena could be possible, if we
examine the striated skeletal muscle apparatus we know that this
voluntary group nerve supply is under conscious control because
these nerves are branches of the peripheral cerebrospinal nervous
apparatus (the brain and spinal cord as the cerebrospinal axis),
The muscle fibers themselves are tissues composed of contractile
cells that effect movement based on the excitatory process set up
in nerve fibers by stimuli (the nerve impulse). It is presently
believed by medical research that the nerve impulse is probably in
the nature of a wave of electrochemical disturbances. The
efficiency with which the nerve impulse controls a specific muscle
group can be defined as the number of muscle fibers utilized in a
contraction divided by the number of fibers present in that muscle
group. It is presently believed that most humans only contract a
small percentage of muscle fibers in a given group for a given
nerve impulse (low efficiency of muscle mass usage per nerve
impulse contraction).
[0061] If now we were to induce a condition in which the total
power of the electrochemical nerve impulse could be increased so
that more muscle fibers could contract for a given nerve impulse,
the net efficiency of the striated fibers would increase (more
muscle fibers in a group being contracted for a nerve impulse), and
hence usable physical strength could be improved. This is one
possible explanation for the phenomena associated with beneficial
effects, for example, immediate and demonstrable increases in
strength and stamina within seconds of wearing the wearable
apparatus of the present invention.
[0062] This phenomena is not unusual or unknown in other devices.
For example, in physical therapy electrical signals are utilized
for the purpose of forcing voluntary muscle groups to contract
under stimulation. These devices are commonly known as electrical
or electronic muscle stimulators (EMS) and cause stimulated
contraction and relaxation phases of muscle groups. According to
another embodiment, the invention provides an apparatus for, based
on the mode of operation as presented, an improvement in net
efficiency of total muscle mass utilized during a contraction phase
that may be achieved due to an increase in electron flow during the
wave of electrochemical disturbances created by the nerve
impulse.
[0063] According to another aspect, the invention provides an
apparatus that passively modulates the oscillating low energy
magnetic field that exists just above the surface of the human
epidermal layer. This passive frequency modulation creates a
condition in which the transport of long chain fatty acids across
the mitochondrial membrane for subsequent beta-oxidation and energy
production is triggered or improved, thereby providing a user of
the apparatus with increased energy via an increase in ATP
production as described above.
[0064] To understand this phenomenon, the metabolic process
involving fatty acid energy sources within the human body can be
examined. Fatty acids, a hydrocarbon in which one of the hydrogen
atoms has been replaced by a carboxyl group, are also described as
a monobasic aliphatic acid made up of an alkyl radical attached to
a carboxyl group. The metabolic role of fatty acids may be
described in part in that fatty acids are one of the primary
sources of energy for humans and, through Beta-Oxidation, are
broken down into basic units of energy. Of interest here is that,
in order for this process to work, fatty acids need to enter the
mitochondria for Beta-Oxidation, and they are unable to penetrate
the inner mitochondrial membrane by themselves. In the human body,
to overcome the problem of the inability of fatty acids to
transport from the cytosol (soluble portion of the cell) across the
mitochondrial membrane, it has been determined by several
researchers that various nutrients are essential to transport long
chain fatty acids from the cytosol across the mitochondrial
membrane for fatty acid oxidation/metabolism and energy
production.
[0065] According to the invention, in order to obtain the desirable
effect of improving cell metabolism passively (specifically,
increasing the rate of fatty acid Beta-Oxidation by allowing fatty
acids to transport across the mitochondrial membrane), an apparatus
consisting of orthomolecular organic structures can be designed to
passively interact with the human magnetic field for the purpose of
creating a system of frequency modulation, much in the same way
that radio waves are modulated to communicate audio
information.
[0066] According to an embodiment of the invention, an apparatus
100 that causes a beneficial effect by regulating thermomagnetic
energy-flow within a human body are illustrated in FIGS. 2A, 2B,
3A, and 3B.
[0067] According to another embodiment, the invention provides
apparatus 100 comprising biomolecular components that may include
molecules associated with building-up of energy (e.g.,
thermomagnetic energy). In some embodiments, biomolecular
components may include a Left-Handed molecule such as, for example,
an amino acid. In one embodiment, the apparatus may include a
structure that may be used for promoting the flow of energy
(electrons) within a human body so as to improve physical strength
of a user, wherein the structure may include a Left-Handed molecule
such as, for example, an amino acid.
[0068] The Left-Handed amino acids are known in those skilled in
the art, and as such a complete description of the Left-Handed
amino acids need not be given here, but suffice it to say that
suitable Left-Handed amino acids for use in the invention may
include, for example, L-Glutamine, L-Arginine, L-Ornithine,
L-Camitine, L-Taurine, L-Tryptophan, L-Glycine, etc. Preferably,
the amino acids used in the invention are orthomolecular amino
acids.
[0069] In some embodiments, the Left-Handed molecule is an amino
acid found in nature. In other embodiments, the Left-Handed
molecule is an amino acid synthesized by man. The examples of amino
acids may include, but not limited to, L-Alanine, L-Arginine,
L-Aspargine, L-Aspartic Acid, L-Carnitine, Acetyl-L-Carnitine,
L-Camitine L-Tartrate, L-Camitine Magnesium Citrate, L-Citrulline,
L-Cystine, L-Cystine, L-GABA, L-Glutamic Acid, L-Glutamine,
Glutathione Peroxidase, L-Glycine, L-Histidine, Hydroxyglutamic
Acid, Hydroxyproline, L-Isoleucine, L-Leucine, Norleucine,
L-Lysine, L-Methionine, L-Omithine, L-Valine, L-Phenylalanine,
L-Proline, L-Serine, L-Taurine, L-Threonine, L-Tryptophan,
L-Tyrosine, etc. In some embodiments, the Left-Handed molecules may
include a synthetic L-sugar (L-glucose) or other synthetic
levo-rotatory molecule known to one skilled in the art.
[0070] According to another embodiment of the invention, the
Left-Handed molecule may be employed in a variety of ways. In one
example, the biomolecular components including the Left-Handed
molecules may be used in the form of a liquid, with said liquid
being sprayed or similarly applied to a substrate. In another
example, the biomolecular components including the Left-Handed
molecule may be used in the form of a solid, such as a powder, with
said powder being mixed with a binder such as latex rubber,
silicone rubber, epoxy, wax or the like, with the powdered amino
acid and binder being applied to a substrate.
[0071] According to another embodiment, the invention may include a
structure that includes a plurality of Left-Handed molecules. In
other words, more than one kind of Left-Handed molecules may be
utilized in a structure. In one example, a structure in which
L-glutamine may be applied to a single substrate, followed by the
layering of a second amino acid such as L-Arginine to a second
substrate, with both treated substrates forming part of the
completed structure of the invention. In some embodiments, portions
of L-Glutamine and L-Arginine may be mixed together, and then
applied in the form of a liquid or powder to a single substrate. In
another example, two or more L amino acids may be applied to the
same substrate.
[0072] According to another embodiment, the invention provides an
apparatus comprising biomolecular components that may include
molecules associated with dilution of energy (e.g., thermomagnetic
energy). In some embodiments, the biomolecular components may
include Right-Handed molecules such as, for example, an amino acid.
In one embodiment, the apparatus may include a structure that may
be used for negating flow of energy (electrons) within a human body
so as to decrease physical strength of a user or relax the user,
wherein the structure may include Right-Handed molecules such as,
for example, an amino acid or sugar.
[0073] The Right-Handed amino acids and Right-Handed sugars are
known to those skilled in the art, and as such a complete
description of these materials need not be given here, but suffice
it to say that suitable Right-Handed amino acids (i.e., D amino
acids) for use in the present invention may include, for example,
D-Glutamine, D-Arginine, D-Ornithine, D-Camitine, D-Taurine,
D-Tryptophan, D-Glycine, D-Glutamic Acid, etc.
[0074] In some embodiments, the Right-Handed molecule is an amino
acid found in nature. In other embodiments, the Right-Handed
molecule is an amino acid synthesized by man. The Examples of the
Right-Handed molecule may include, but not limited to, D-Alanine,
D-Arginine, D-Aspargine, D-Aspartic Acid, D-Camitine,
Acetyl-D-Camitine, D-Camitine D-Tartrate, D-Camitine Magnesium
Citrate, D-Citrulline, D-Cysteine, D-Cystine, D-GABA, D-Glutamic
Acid, D-Glutamine, D-Glutathione Peroxidase, D-Glycine,
D-Histidine, D-Hydroxyglutamic Acid, D-Hydroxyproline, D-Soleucine,
D-Leucine, D-Norleucine, D-Lysine, D-Metbionine, D-Omithine,
D-Valine, D-Phenylalanine, D-Proline, D-Serine, D-Taurine,
D-Threonine, D-Tryptophan, D-Tyrosine, etc.
[0075] According to another embodiment, the Right-Handed molecules
may include one or more sugars, for example, but not limited to
dextrin, dextrose, fructose, galactose, glucose, glycogen, high
fructose corn syrup, honey, inositol, invert sugar, lactose,
levulose, maltose, molasses, sucrose, sugar cane, and xylose etc.
Preferably, the Right-Handed amino acids used in the invention are
non-orthomolecular amino acids.
[0076] According to another embodiment of the invention, the
Right-Handed molecules may be employed in a variety of ways. In one
example, the biomolecular components including the Right-Handed
molecules may be used in the form of a liquid, with said liquid
being sprayed or similarly applied to a substrate. In another
example, biomolecular components including the Right-Handed
molecules may be used in the form of a solid, such as a powder,
with said powder being mixed with a binder such as latex rubber,
silicone rubber, epoxy, wax or the like, with the powdered amino
acid and binder being applied to a substrate.
[0077] According to another embodiment, the invention may include a
structure that includes a plurality of Right-Handed molecules. In
other words, more than one kind of Right-Handed molecules may be
used in a structure. In one example, a structure in which
D-Glutamic acid may be applied to a single substrate, followed by
the layering of a second D amino acid to a second substrate, with
both treated substrates forming part of the completed structure of
the invention. In some embodiments, portions of D-Glutamc acid and
a second D amino acid may be mixed together, and then applied in
the form of a liquid or powder to a single substrate. In another
example, two or more D amino acids may be applied to the same
substrate.
[0078] According to another embodiment, the invention provides an
apparatus including one or more substrates for the biomolecular
components regulating thermomagnetic energy flow within a human
body. In some embodiments, the one or more substrates may include,
for example, but not limited to a polyester fabric sheet, a cotton
fabric sheet, etc. In one embodiment, the one or more substrates
may be used for the Left-Handed molecules. In another embodiment,
the one or more substrates may be used for the Right Handed
molecules. The one or more substrates may not react (chemically,
etc.) with the Left-Handed molecules and the Right-Handed molecules
of the invention. The examples of substrates may include, for
example, but not limited to polyester fabric sheet (e.g.,
manufactured by Pellon, # 910, an interfacing material for
lightweight to featherweight fabrics, etc.), cotton fabric sheet,
etc. In one embodiment, either the polyester fabric sheet or the
cotton fabric sheet may be used in construction of the apparatus of
the invention. In another embodiment, both the polyester fabric
sheet and the cotton fabric sheet may be used in construction of
apparatus 100 of the invention.
[0079] According to another embodiment, the invention may include
one or more additives for the Left-Handed molecules and/or
Right-Handed molecules. The examples of additives may include, but
not limited to Glycerin, d-calcium pantothenate, sorbitol,
propylparaben, potassium sorbate, methylparaben, Colloidal Gold,
etc.
[0080] According to another embodiment, the invention provides an
apparatus including a sealed enclosure, wherein the sealed
enclosure may enclose biomolecular components (e.g., Left-Handed
molecules, Right-Handed molecules) regulating thermomagnetic energy
flow within the human body and one or more substrates for the
biomolecular components. The sealed enclosure may be made of a
material, for example, but not limited to a polyester film sheet
(e.g., manufactured by GBC, a thermal laminating film, etc.), a
plastic film (e.g., polyethylene, polypropylene, ABS, plexiglass,
lexan, pvc, etc), etc. In one embodiment, the polyester film sheet
and/or the plastic film may be utilized in construction of the
apparatus of the invention. In some embodiments the sealed
enclosure may be made of a light polarizing film. In other
embodiments the sealed enclosure may be made of a linear low
density film.
[0081] According to another embodiment of the invention, the sealed
enclosure may not react (i.e., chemically, etc.) with biomolecular
components (e.g., Left-Handed molecules, Right-Handed molecules) of
the invention. In some embodiments, the sealed enclosure may be
capable of being sealed in a predefined fashion to keep the
Left-Handed molecules and/or the Right-Handed molecules in a liquid
state. In some embodiments, the sealed enclosure may be capable of
being sealed in a predefined fashion to protect the Left-Handed
molecules and/or the Right-Handed molecules from ambient
environmental conditions.
[0082] Methods of sealing plastic films are known to those skilled
in the art and will not be described here in detail. Examples of
such methods of sealing plastic films may include, for example,
pressure sensitive or thermally sensitive adhesives, ultrasonic
sealing, etc.
[0083] According to another embodiment, the invention provides an
apparatus that includes a sealed plastic enclosure that encloses
biomolecular components regulating thermomagnetic energy flow
within the human body and one or more substrates for the
biomolecular components, wherein the apparatus further includes one
or more gem stones (e.g., Jade, powdered jade, etc.).
[0084] In one embodiment, Jade may be used for decorative purposes,
and for the practice of the invention. Jade (or other gem stones)
may be incorporated into the invention in either gem stone form, or
in powdered form. If Jade is incorporated in stone form, then the
apparatus of the invention may be embodied as decorative items such
as jewelry, etc. If Jade is incorporated in powdered form, then the
Jade powder may be added to the Left-Handed molecules and/or the
Right-Handed molecules. The Jade may also be added in other parts
of the devices of the invention so as to make the apparatus
practical for use.
[0085] According to another embodiment, the invention provides one
or more physical structural settings for holding one or more
components of apparatus 100. In some embodiments, that the one or
more physical structural settings may hold biomolecular components
regulating thermomagnetic energy flow within the human body, one or
more substrates for the biomolecular components, and one or more
gem stones (e.g., Jade, powdered jade, etc.).
[0086] According to another embodiment, apparatus 100 may be in one
or more of a plurality of wearable objects, for example, but not
limited to dermal patches, bracelets, pendants, support pads,
shirts, socks, foot inserts, etc.
[0087] According to another embodiment, the invention may include a
patch having an adhesive (e.g., medical grade adhesive). In some
embodiments, the invention may include a single patch. In other
embodiments, the invention may include a plurality of patches. In
one embodiment, the patch may be constructed in layers made of
plastic film or light polarizing film, polyester fabric as a
substrate, Water, L-Camitine, Glycerin, d-calcium pantothenate,
sorbitol, propylparaben, potassium sorbate, and methylparaben. In
another embodiment, the patch may be constructed in layers made of
a plastic film or a light polarizing film as an enclosure, a
polyester fabric as a substrate, Honey and Molasses.
[0088] If apparatus 100 of the present invention is embodied as
jewelry items, then the apparatus may be mounted in virtually any
jewelry setting that is already commercially available, provided
that the setting does not interfere in any way with the operation
of apparatus 100 of the present invention. If apparatus 100 of the
invention is embodied in "Band Aid" style or "Transdermal Patch"
style, then a setting would not be needed. In one embodiment,
apparatus 100 of the invention may be completely sealed, thereby
the Left-Handed molecules and/or the Right-Handed molecules may not
make direct contact with a user of apparatus 100. In addition, the
Left-Handed molecules and/or the Right-Handed molecules may not
enter into body of the user.
[0089] In some embodiments, Apparatus 100 of the invention having
Left-Handed molecules may be manufactured with the following
specifications:
[0090] 500 mg of L-Glutamine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Glutamine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0091] In other embodiments, Apparatus 100 of the invention having
Right-Handed molecules may be manufactured with the following
specifications:
[0092] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0093] According to another embodiment, the invention provides a
method for placing apparatus 100 on a predetermined location of a
human body or into a human body, wherein apparatus 100 produces a
beneficial effect when placed on the human body or into the human
body, wherein apparatus 100 regulates thermodynamic energy-flow
within the human body for producing the beneficial effect. The
apparatus 100 may include, for example, patch, bracelet, necklace,
anklet, etc.
[0094] According to another embodiment, the invention provides
methods for placing apparatus 100 of the invention into proximity
of a human body. In one example, apparatus 100 of the invention may
be attached to pendants, and allowed to be placed into proximity of
the human body. In another example, apparatus 100 of the invention
may be embodied in "Band Aid" style or "Patch" style, with a
medical grade adhesive being applied to the device to make it
suitable for use with human beings.
[0095] In one embodiment, apparatus 100 (e.g., dermal patch) may be
placed on forearms of a user for producing a beneficial effect such
as, for example, improvement in strength or stamina. In some
embodiments, apparatus 100 (e.g., dermal patch) having Left-Handed
molecules may be placed on the palm side of the right forearm of
the user. In other embodiments, apparatus 100 (e.g., dermal patch)
having Right-Handed molecules may be placed on the palm side of the
left forearm of the user.
[0096] For strength and stamina, apparatus 100 (e.g., dermal patch)
may be placed at Pericardium 4 (P4) located about 4 inches below
the wrist.
[0097] For relief of sinus congestion, apparatus 100 (e.g., dermal
patch) may be placed on Large Intestine 14 (LI 14). In some
embodiments, apparatus 100 (e.g., dermal patch) having Left-Handed
molecules may be placed on RIGHT shoulder and apparatus 100 (e.g.,
dermal patch) having Right-Handed molecules may be placed on left
shoulder for relief of sinus congestion.
[0098] For relief of menstrual cramps, woman may place apparatus
100 (e.g., dermal patch) having Left-Handed molecules at the
depression on the midline of the chest and apparatus 100 (e.g.,
dermal patch) having Right-Handed molecules at about 1-2 inches
below the belly button (where the cramps are).
[0099] For relief of knee pain from arthritis, apparatus 100 (e.g.,
dermal patch) having Left-Handed molecules may be placed along the
midline at the depression between the chest and apparatus 100
(e.g., dermal patch) having Right-Handed molecules may be placed
where the pain is on the knee.
[0100] In a preferred embodiment, apparatus 100 (e.g., dermal
patch) having Left-Handed molecules may be placed at an
electrically POSITIVE point on the body and apparatus 100 (e.g.,
dermal patch) having Right-Handed molecules may be placed at an
electrically NEGATIVE point on the body. Positive and Negative
points on the body have been metered and been well known by
physiologists for about 30 years+.
[0101] Furthermore, apparatus 100 (e.g., dermal patch) may be
placed at known acupuncture points. For example, apparatus 100
having Left-Handed molecules (e.g., POSITIVE dermal patch) may be
placed at a YANG (positive) point and apparatus 100 (e.g., dermal
patch) having Right-Handed molecules (e.g., NEGATIVE dermal patch)
may be placed at a TIN (negative) point.
[0102] According to another embodiment of the invention illustrated
in FIG. 2A, apparatus 100 that causes a beneficial effect (e.g.,
improvement in strength/stamina, relief from a pain, etc.) by
regulating thermomagnetic energy flow within a human body may
include a single layer fabric substrate 110 for retaining
biomolecular components including, for example, molecules for
building-up of energy (e.g., thermomagnetic energy) and/or
molecules for dilution of energy (e.g., thermomagnetic energy).
Apparatus 100, as illustrated, may be fabricated in accordance with
the principles as described here in the preceding disclosure.
[0103] FIG. 2B illustrates a sealed single layer fabric substrate
that retain the biomolecular components.
[0104] According to another embodiment of the invention illustrated
in FIG. 3A, apparatus 100 that causes a beneficial effect (e.g.,
improvement in strength/stamina, relief from a pain, etc.) by
regulating thermomagnetic energy-flow within a human body may
include two layers of fabric substrate 120 for retaining
biomolecular components including, for example, molecules for
building-up of energy (e.g., thermomagnetic energy) and/or
molecules for dilution of energy (e.g., thermomagnetic energy).
Apparatus 100, as illustrated, may be fabricated in accordance with
the principles as described here in the preceding disclosure.
[0105] FIG. 3B illustrates a sealed multi layer fabric substrate
that retain the biomolecular components.
[0106] According to another embodiment of the invention illustrated
in FIG. 4, a patch 400 may include apparatus 100 for causing a
beneficial effect (e.g., improvement in strength/stamina, relief
from a pain, etc.) for a human body by regulating thermomagnetic
energy flow within the human body. In some embodiments, one or more
portions of patch 400 may include medical grade adhesive for
enabling attachment of patch 400 to human skin surface.
[0107] According to another embodiment of the invention illustrated
in FIG. 5, a bracelet 500 may include apparatus 100 for causing a
beneficial effect (e.g., improvement in strength/stamina, relief
from a pain, etc.) for a human body by regulating thermomagnetic
energy flow within the human body. In some embodiments, bracelet
500 may also include a gem stone (not shown in FIG. 5).
[0108] According to another embodiment of the invention illustrated
in FIG. 6, a ring 600 may include apparatus 100 for causing a
beneficial effect (e.g., improvement in strength/stamina, relief
from a pain, etc.) for a human body by regulating thermomagnetic
energy flow within the human body. In some embodiments, ring 600
may also include a gem stone 610.
[0109] According to another embodiment of the invention illustrated
in FIG. 7, a watch 700 may include apparatus 100 for causing a
beneficial effect (e.g., improvement in strength/stamina, relief
from a pain, etc.) for a human body by regulating thermomagnetic
energy flow within the human body.
EXAMPLES
Example 1
[0110] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0111] 500 mg of L-Carnitine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
The interfacing material is dipped in the L-Carnitine solution so
as to saturate the fabric with the solution. The saturated fabric
disk is then sandwiched and placed between 2 layers of the heat
laminating film, and the structure is sealed with a heating surface
so as to form the completed structure.
[0112] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0113] Honey in its raw form (Sioux Honey) is utilized as the patch
ingredient. A Pellon 100% polyester interfacing material is cut to
a 1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. The interfacing material is dipped in the Honey so as to
saturate the fabric with the solution. The honey-saturated fabric
disk is then sandwiched and placed between 2 layers of the heat
laminating film, and the structure is sealed with a heating surface
so as to form the completed structure.
[0114] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 2
[0115] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0116] 500 mg of L-Camitine is added to 15 ml of distilled water; A
Pellon 100% polyester interfacing material is cut to a 1" diameter
disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the L-Camitine
solution so as to saturate the fabrics with the solution. The
saturated fabric disks are then sandwiched and placed between
separate layers of the heat laminating film (the saturated disks
are separated from one another by plastic films), and the structure
is sealed with a heating surface so as to form the completed
structure.
[0117] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0118] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0119] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches. This formulation was utilized
in the Morehouse College Clinical Study and the Troy State
University Clinical Study.
Example 3
[0120] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0121] 500 mg of L-Glutamine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Glutamine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0122] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0123] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0124] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 15% on average when using this formulation as
opposed to not using these patches.
Example 4
[0125] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0126] 500 mg of L-Camitine is added to 15 ml of distilled water;
To this solution small amounts of preservatives are added so as to
prevent the formation of mold or bacteria. In this case the
preservatives that are added are glycerin, potassium sorbate,
methylparaben and propylparaben. A Pellon 100% polyester
interfacing material is cut to a 1" diameter disk; GBC Heat
Laminating films (# 3000038 clear polyester substrate with
homopolymer adhesive) are cut to 1.69" in diameter. Two pieces of
the interfacing material are dipped in the L-Glutamine solution so
as to saturate the fabrics with the solution. The saturated fabric
disks are then sandwiched and placed between separate layers of the
heat laminating film (the saturated disks are separated from one
another by plastic films), and the structure is sealed with a
heating surface so as to form the completed structure.
[0127] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0128] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredients. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0129] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 5
[0130] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0131] 500 mg of L-Glutamine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Glutamine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0132] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0133] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0134] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 15% on average when using this formulation as
opposed to not using these patches.
Example 6
[0135] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0136] 500 mg of acetyl-L-Carnitine is added to 15 ml of glycerin;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
acetyl-1-carnitine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0137] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0138] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0139] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 25% on average when using this formulation as
opposed to not using these patches.
Example 7
[0140] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0141] 500 mg of acetyl-1-carnitine and 100 mg of L-Omithine are
added to 30 ml of glycerin; A Pellon 100% polyester interfacing
material is cut to a 1" diameter disk; GBC Heat Laminating films (#
3000038 clear polyester substrate with homopolymer adhesive) are
cut to 1.69" in diameter. Two pieces of the interfacing material
are dipped in the amino acid solution so as to saturate the fabrics
with the solution. The saturated fabric disks are then sandwiched
and placed between separate layers of the heat laminating film (the
saturated disks are separated from one another by plastic films),
and the structure is sealed with a heating surface so as to form
the completed structure.
[0142] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0143] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0144] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 25% on average when using this formulation as
opposed to not using these patches.
Example 8
[0145] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0146] 500 mg of acetyl-1-carnitine and 100 mg of L-Arginine are
added to 30 ml of glycerin; A Pellon 100% polyester interfacing
material is cut to a 1" diameter disk; GBC Heat Laminating films (#
3000038 clear polyester substrate with homopolymer adhesive) are
cut to 1.69" in diameter. Two pieces of the interfacing material
are dipped in the amino acid solution so as to saturate the fabrics
with the solution. The saturated fabric disks are then sandwiched
and placed between separate layers of the heat laminating film (the
saturated disks are separated from one another by plastic films),
and the structure is sealed with a heating surface so as to form
the completed structure.
[0147] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0148] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0149] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 15% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 25% on average when using this formulation as
opposed to not using these patches.
Example 9
[0150] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0151] 500 mg of L-Arginine is added to 15 ml of distilled water; A
Pellon 100% polyester interfacing material is cut to a 1" diameter
disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the L-Arginine
solution so as to saturate the fabrics with the solution. The
saturated fabric disks are then sandwiched and placed between
separate layers of the heat laminating film (the saturated disks
are separated from one another by plastic films), and the structure
is sealed with a heating surface so as to form the completed
structure.
[0152] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0153] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0154] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 10
[0155] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0156] 500 mg of L-Ornithine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Ornithine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0157] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0158] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0159] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 11
[0160] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0161] 500 mg of L-Glutamic Acid is added to 15 ml of distilled
water; A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the L-Glutamic
Acid solution so as to saturate the fabrics with the solution. The
saturated fabric disks are then sandwiched and placed between
separate layers of the heat laminating film (the saturated disks
are separated from one another by plastic films), and the structure
is sealed with a heating surface so as to form the completed
structure.
[0162] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0163] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0164] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 15% on average when using this formulation as
opposed to not using these patches.
Example 12
[0165] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0166] 500 mg of L-Glycine is added to 15 ml of distilled water; A
Pellon 100% polyester interfacing material is cut to a 1" diameter
disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the L-Glycine
solution so as to saturate the fabrics with the solution. The
saturated fabric disks are then sandwiched and placed between
separate layers of the heat laminating film (the saturated disks
are separated from one another by plastic films), and the structure
is sealed with a heating surface so as to form the completed
structure.
[0167] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0168] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0169] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 15% on average when using this formulation as
opposed to not using these patches.
Example 13
[0170] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0171] 150 mg of L-Isoleucine, 150 mg of L-Leucine and 150 mg of
L-Valine are added to 30 ml of distilled water; A Pellon 100%
polyester interfacing material is cut to a 1" diameter disk; GBC
Heat Laminating films (# 3000038 clear polyester substrate with
homopolymer adhesive) are cut to 1.69" in diameter. Two pieces of
the interfacing material are dipped in the amino acid solution so
as to saturate the fabrics with the solution. The saturated fabric
disks are then sandwiched and placed between separate layers of the
heat laminating film (the saturated disks are separated from one
another by plastic films), and the structure is sealed with a
heating surface so as to form the completed structure.
[0172] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0173] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0174] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 25% on average when using this formulation as
opposed to not using these patches.
Example 14
[0175] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0176] 500 mg of L-Methionine is added to 15 ml of distilled water;
A Pellon 100% polyester interfacing material is cut to a 1"
diameter disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the
L-Methionine solution so as to saturate the fabrics with the
solution. The saturated fabric disks are then sandwiched and placed
between separate layers of the heat laminating film (the saturated
disks are separated from one another by plastic films), and the
structure is sealed with a heating surface so as to form the
completed structure.
[0177] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0178] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0179] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 15
[0180] Patch 400 of the invention having Left-Handed molecules may
be manufactured with the following specifications:
[0181] 500 mg of L-Taurine is added to 15 ml of distilled water; A
Pellon 100% polyester interfacing material is cut to a 1" diameter
disk; GBC Heat Laminating films (# 3000038 clear polyester
substrate with homopolymer adhesive) are cut to 1.69" in diameter.
Two pieces of the interfacing material are dipped in the L-Taurine
solution so as to saturate the fabrics with the solution. The
saturated fabric disks are then sandwiched and placed between
separate layers of the heat laminating film (the saturated disks
are separated from one another by plastic films), and the structure
is sealed with a heating surface so as to form the completed
structure.
[0182] Patch 400 of the invention having Right-Handed molecules may
be manufactured with the following specifications:
[0183] Honey in its raw form (Sioux Honey) and unsulphured Molasses
(Grandma Molasses) is utilized as the patch ingredient. The ratio
of Honey to Molasses is 3 lb. of honey by weight to 355 ml of
Molasses. A Pellon 100% polyester interfacing material is cut to a
1" diameter disk; GBC Heat Laminating films (# 3000038 clear
polyester substrate with homopolymer adhesive) are cut to 1.69" in
diameter. Two pieces of the interfacing material are dipped in the
Honey/Molasses solution so as to saturate the fabric with the
solution. The honey/molasses-saturated fabric disks are then
sandwiched and placed between layers of the heat laminating film
(the saturated disks are separated from one another by plastic
films), and the structure is sealed with a heating surface so as to
form the completed structure.
[0184] The above patches were tested with users by placing patch
400 having Left-Handed molecules on the right arms and patch 400
having Right-Handed molecules on the left arms; it was found that
when using a hand dynamometer there was an average 10% increase in
hand strength when using these patches as opposed to not using
them. In other tests it was found that strength endurance (stamina)
was increased over 20% on average when using this formulation as
opposed to not using these patches.
Example 16
[0185] The invention provides a new supplement and method for the
improvement of athletic performance, and more particularly a means
by which an individual may increase their net stamina/strength
endurance output. To quantitatively assess the effectiveness of the
invention in improving the bench press performance of fatigued
college football athletes during team training, a double-blind
placebo controlled study was implemented at Morehouse College in
Atlanta, Ga., with 44 college athletes from the school's football
team volunteering to participate in this study. In most evaluations
of strength endurance involving competitive athletes, it is common
and customary to perform both baseline and comparative tests prior
to the athlete having performed any other type of physical
activity. In this study, both baseline and comparative data were
collected after the athletes had been fatigued by a 60-minute heavy
weight-training workout. In addition, it was also decided to test
the athletes while under heavy physical trauma. The athletes
performed the workout and tests starting at 4:30 a.m. in a weight
training room where the temperature was maintained in excess of
95.degree. F. The standardized exercise that was chosen for this
test was a 185 pound or 225 pound bench press.
[0186] Using a double-blind randomized placebo controlled study, a
total of 44 subjects, ages 18 to 30 years, volunteered to
participate for this study. Subjects' baseline bench press data was
collected after a normal prescribed off-season football upper body
60-minute workout session. Subjects were asked to bench press a
fixed weight until failure.
[0187] In the next session, subjects were randomized into three
groups using a numbering system that labeled participants as
experiment group, placebo group or control group members with 44
completing this two-session study. The placebo group was provided
with dermal patches that had placebo water formula. The
experimental group was provided with experimental dermal patches.
The experimental dermal patches included either patch 400 having
Left-Handed molecules or patch 400 having Right-Handed molecules or
both. In the experimental group, patch 400 having left-handed
molecules was placed on the palm side of the right forearm of the
participants, and patch 400 having right-handed molecules was
placed on palm side of the left forearm of the participants. In the
placebo group, placebo dermal patches were placed on palm sides of
both the left arm and the right arm of the participants. A
collection team independent of the players collected and monitored
data throughout the study process.
[0188] Data collected from the two-day study was as follows. All
numbers listed are repetitions performed:
1 CONTROL GROUP PLACEBO GROUP EXPERIMENT GROUP Baseline Comparative
% Change Baseline Comparative % Change Baseline Comparative %
Change 6 4 -33 8 8 0 12 10 -17 10 12 20 7 8 14 1 3 200 9 11 22 5 6
20 6 12 100 5 5 0 4 3 -25 4 6 50 12 12 0 6 3 -50 2 3 50 10 10 0 15
18 20 5 3 -40 10 9 -10 12 10 -17 9 9 0 2 3 50 11 13 18 11 15 36 3 0
-100 12 12 0 3 4 33 4 4 0 7 10 43 18 16 -11 10 12 20 16 21 31 15 16
7 5 4 -20 20 23 15 6 9 50 10 9 -10 9 7 -22 16 16 0 5 5 0 4 5 25 15
15 0 8 10 25 10 11 10
[0189] From the data collected in the above table, it was
determined that (1) the average percentage change in strength
endurance in the Control group was a decrease in performance of
3.1% from the baseline tests to the comparative tests; (2) the
average percentage change in strength endurance in the Placebo
group was an increase in performance of 3.6% from the baseline
tests to the comparative tests; (3) the average percentage change
in strength endurance in the Experiment group was an increase in
performance of 33.9% from the baseline tests to the comparative
tests.
[0190] In addition, the data shows the following:
2 CONTROL GROUP PLACEBO GROUP EXPERIMENT GROUP Decrease Same
Increase Decrease Same Increase Decrease Same Increase 5 6 5 4 2 7
3 2 10
[0191] In the Control group, applicants found that 31.25% of the
participants showed a decrease in performance during the two-day
study, 37.5% of the participants maintained the same level of
performance during the two-day study, and 31.25% of the
participants showed an increase in performance during the two-day
study. In the Placebo group, applicants found that 30.8% of the
participants showed a decrease in performance during the two-day
study, 15.4% of the participants maintained the same level of
performance during the two-day study, and 53.8% of the participants
showed an increase in performance during the two-day study. In the
Experiment group, applicants found that 20% of the participants
showed a decrease in performance during the two-day study, 13.33%
of the participants maintained the same level of performance during
the two-day study, and 66.67% of the participants showed an
increase in performance during the two-day study.
[0192] After removing the data for the individuals who both
decreased in performance and maintenance the same level of
performance, applicants found that (1) in the Control group, with
respect to the 5 individuals who did show an improvement in
performance from the baseline to the comparative test, the average
increase in strength endurance was 24.4%; (2) in the Placebo group,
with respect to the 7 individuals who did show an improvement in
performance from the baseline to the comparative test, the average
increase in strength endurance was 23%; (3) in the Experimental
group, with respect to the 10 individuals who did show an
improvement in performance from the baseline to the comparative
test, the average increase in strength endurance was 57.6%.
[0193] After removing the data for the individuals who both
increased in performance and maintained the same level of
performance, applicants found that (1) in the Control group, with
respect to the 5 individuals who decreased in performance from the
baseline to the comparative test, the average decrease in strength
endurance was 34.6%; (2) in the Placebo group, with respect to the
4 individuals who decreased in performance from the baseline to the
comparative test, the average decrease in strength endurance was
28.5%; (3) in the Experiment group, with respect to the 3
individuals who decreased in performance from the baseline to the
comparative test, the average decrease in strength endurance was
22.67%.
[0194] Based on the data collected, it is evident that there are
several distinct differences in athletic performance between the
three test groups. With respect to the simple averaging of
performance numbers, it is not unusual that the Control group
experienced a decrease in strength endurance given the nature of
the test (baseline data collected on a Monday and comparative data
collected on a Thursday; data collected after athletes were
fatigued). With respect to the Placebo group, a case could be made
that there was indeed a "Placebo effect" that took place; athletes
that wore the patch product thought that they had the real
technology so, hence, they made more of an effort to perform. Given
the data of the average group performance improvement of 3.6%, this
would be a reasonable spread in terms of attainable improvements
from the baseline day to the comparative day. With respect to the
Experiment group, a case could be made that there was indeed a
significant effect of the experimental dermal patch on athletic
performance; athletes that wore the patch product experienced an
average improvement of 33.9% in strength performance. The spreads
in average performance numbers between the three groups is
significant and would tend to indicate that the experimental dermal
patch played an important role in improving strength endurance in
the experiment group.
[0195] Another indicator that the experimental dermal patch was
having a significant effect on athletic stamina is evidenced in the
chart. As could be expected, in the Control group, there is an
almost even distribution between athletes that decreased in
performance, athletes that remained the same in performance, and
athletes that improved in performance. In the Placebo group, 7
individuals improved in performance as compared to 5 in the Control
group. However, given the low average improvement in members and
the well-known "Placebo effect," this spread is anticipated. In the
Experiment group, only 3 members decreased in performance, with 10
members improving in strength endurance. Given that the Experiment
group had the highest percentage of members who recorded an
improvement in performance, with two-thirds of the members
demonstrating an improvement, and that the average improvement was
significantly higher than the other two groups (33.9%), this would
again indicate that the experimental dermal patch was having a
beneficial effect on athletic performance. Another potentially
important indicator with respect to examining whether or not the
experimental dermal patch was having a beneficial effect on
athletic performance is found when looking at only those
individuals who increased in performance or only those individuals
who decreased in performance. In the Control group, applicants
found that of those individuals how did show an improvement, the
average gain was 24.4%; of those in the Control group who decreased
in performance, the average decline in performance was 34.6%. In
the Placebo group, applicants found that of those individuals who
did show an improvement, the average gain was similar to the
Control group at 23%; of those in the Placebo group who decreased
in performance, applicants found that the average decline in
performance was 28.5%. In the Experiment group, applicants found
that of those individuals who did show an improvement, the average
gain was more than double of the other two groups at 57.6%; of the
three individuals who showed a decrease in performance, the average
decline in performance was the lowest of the three groups at
22.67%. This information clearly indicates that the experimental
dermal patch was having a beneficial effect on strength
endurance.
[0196] Based on the data collected and the results obtained, it was
demonstrated that the invention (i.e., experimental dermal patch)
provides a method for the improvement of athletic performance, and
more particularly a means by which an individual may increase their
net stamina/strength endurance output. It was also demonstrated
that the Experiment group using the invention (i.e., experimental
dermal patch showed the highest percentage of improvement in
strength endurance when averaging all members, the highest
percentage of improvement in strength endurance when averaging only
those members who showed an improvement, and the lowest percentage
of decreased performance when averaging only those individuals who
showed a decline in performance.
Example 17
[0197] The invention provides a new supplement and method for the
improvement of athletic performance, and more particularly a means
by which individuals may substantially increase their net strength
endurance within as quickly as the first use of the product. To
quantitatively assess the effectiveness of the invention in
improving the bench press performance of college football athletes
during team training, a double-blind placebo controlled study was
implemented at Troy State University in Troy, Ala. A standardized
test was selected to measure net gains in strength endurance, and
in this case the exercise that was performed by all athletes was a
225 pound flat bench press. The baseline data for this test was
collected on Thursday Jun. 26, 2003. The comparative data was
collected on the following Wednesday Jul. 2, 2003. Athletes were
divided into three groups: Control, Placebo and Test. The Control
group was tested "as is" on both of these testing days. The Placebo
group was given a set of patches filled with water; this group was
unaware as to whether or not the patches were real or water filled.
The Test group was given a set of patches of the invention; again,
this group was unaware as to the contents of the patches. It should
be emphasized that the athletes used the patches of the invention
only once; the test was performed within 10 minutes of first
applying the patches to the athletes.
[0198] Using a double-blind randomized placebo controlled study, a
total of 25 subjects, ages 18 to 22 years, volunteered to
participate for this test study. Subjects' baseline bench press
data was colleted after a brief warm up period. Subjects were asked
to bench press a fixed 225 pound weight until failure. In the next
session, subjects were randomized into three groups using a
numbering system that labeled participants as Test group, Placebo
group or Control group members with 25 completing this two-session
study. The Test group was provided with non-transdermal patches
that included either patch 400 having Left-Handed molecules or
patch 400 having Right-Handed molecules or both. In the test group,
patch 400 having left-handed molecules was placed on the palm side
of the right forearm of the participants, and patch 400 having
right-handed molecules was placed on palm side of the left forearm
of the participants. The Placebo group was provided with
non-transdermal patches that contained water. In the placebo group,
placebo dermal patches were placed on palm sides of both the left
arm and the right arm of the participants. A collection team
independent of the players collected and monitored data throughout
the study process.
[0199] Data collected from the two-day study was as follows; all
numbers listed are repetitions performed:
3 CONTROL PLACEBO TEST Baseline Comparative {circumflex over (
)}Reps {circumflex over ( )}Percent Baseline Comparative
{circumflex over ( )}Reps {circumflex over ( )}Percent Baseline
Comparative {circumflex over ( )}Reps {circumflex over ( )}Percent
10 10 0 0 23 23 0 0 3 8 +5 +166.7% 4 6 +2 +50% 10 10 0 0 16 15 -1
-6.2% 12 14 +2 +16.7% 7 12 +5 +71.4% 8 9 +1 +12.5% 9 10 +1 +11.1%
21 24 +3 +14.3% 16 18 +2 +12.5% 10 13 +3 +30% 14 8 +6 -42.8% 7 15
+8 +114.3% 5 6 +1 +20% 10 11 +1 +10% 5 8 +3 +60% 20 21 +1 +4.7% 26
27 +1 +3.8% 12 14 +2 +16.7% 18 19 +1 +5.5% 11 17 +6 +54.5% 6 5 -1
-16.7% 18 11 -7 -38.9%
[0200] From the data collected in the above table, and by removing
the highest and lowest scores from each group, it was determined
that (1) the average percentage change in strength endurance in the
Control group was an increase in performance of 8.9% from the
baseline tests to the comparative tests (average 0.875 rep
improvement); (2) the average percentage change in strength
endurance in the Placebo group was an increase in performance of
13.8% from the baseline tests to the comparative tests (average
1.67 rep improvement); and (3) the average percentage change in
strength endurance in the Test group was an increase in performance
of 43.2% from the baseline tests to the comparative tests (average
2.6 rep improvement).
[0201] In addition, the data shows the following:
4 CONTROL GROUP PLACEBO GROUP TEST GROUP Decrease Same Increase
Decrease Same Increase Decrease Same Increase 2 1 7 1 2 5 1 0 6
[0202] The above table provides the breakdown of athletes in each
group as it pertains to showing whether or not an athlete showed a
decrease in performance from baseline to comparative test, remained
the same in performance from baseline to comparative test, or
showed an increase in performance from baseline to comparative
test.
[0203] In the Control group, Applicants found that 20% of the
participants showed a decrease in performance during the two-day
study, 10% of the participants maintained the same level of
performance during the two-day study, and 70% of the participants
showed an increase in performance during the two-day study. In the
Placebo group, Applicants found that 12.5% of the participants
showed a decrease in performance during the two-day study, 25% of
the participants maintained the same level of performance during
the two-day study, and 62.5% of the participants showed an increase
in performance during the two-day study. In the Test group,
Applicants found that 14.3% of the participants showed a decrease
in performance during the two-day study, 0% of the participants
maintained the same level of performance during the two-day study,
and 85.7% of the participants showed an increase in performance
during the two-day study.
[0204] After removing the data for the individuals who both
decreased in performance and maintained the same level of
performance, Applicants found that (1) in the Control group, with
respect to the 7 individuals who did show an improvement in
performance from the baseline to the comparative test, the average
increase in strength endurance was 19.7%; (2) in the Placebo group,
with respect to the 5 individuals who did show an improvement in
performance from the baseline to the comparative test, the average
increase in strength endurance was 30.8%; (3) in the Test group,
with respect to the 6 individuals who did show an improvement in
performance from the baseline to the comparative test, the average
increase in strength endurance was 63.8%.
[0205] After removing the data for the individuals who both
increased in performance and maintained the same level of
performance, Applicants found that (1) in the Control group, with
respect to the 2 individuals who decreased in performance from the
baseline to the comparative test, the average decrease in strength
endurance was 27.8%; (2) in the Placebo group, with respect to the
1 individual who decreased in performance from the baseline to the
comparative test, the decrease in strength endurance was 42.8%; (3)
in the Experiment group, with respect to the 1 individual who
decreased in performance from the baseline to the comparative test,
the decrease in strength endurance was 6.2%.
[0206] Based on the data collected, it is evident that there are
several distinct differences in athletic performance between the
three groups. With respect to the simple averaging of performance
numbers, it is not unusual that all three groups experienced an
increase in strength endurance given the nature of the test
(athletes were in a training session for the upcoming football
season). With respect to the Placebo group, a case could be made
that there was indeed a "Placebo Effect" that took place; athletes
that wore the patch product thought that they had the real
technology so hence they made more of an effort to perform. Given
the data of the average group performance improvement of the
Placebo group of 13.8% (as compared to 8.9% in the Control group),
this would be a reasonable spread in terms of attainable
improvements from the baseline day to the comparative day. With
respect to the Test group, there was indeed a significant effect of
the test dermal patch on athletic performance; athletes that wore
the patch product experienced an average improvement of 43.2% in
strength performance. The spreads in average performance numbers
between the three groups is significant and would tend to indicate
that the test dermal patch played an important role in improving
strength endurance in the test group.
[0207] Another indicator that the test dermal patch was having a
significant effect on athletic stamina is evidenced in the Table.
In all three groups, Applicants found that the majority of the
athletes improved in performance; however, the Control group and
Placebo group showed nearly identical percentages of athletes that
improved, with 70% of the Control group and 62.5% of the Placebo
group. By comparison in the Test group, Applicants found that 85.7%
of the participants experienced an improvement in performance.
Given that the Test group had the highest percentage of members who
recorded an improvement in performance, with 85.7% of the members
demonstrating an improvement, and that the average improvement was
significantly higher than the other two groups (43.2%) this would
again indicate that the test dermal patch was having a beneficial
effect on athletic performance.
[0208] Another important indicator with respect to examining that
the test dermal patch was having a beneficial effect on athletic
performance is found when looking at only those individuals who
increased in performance or only those individuals who decreased in
performance. In the Control group, Applicants found that, of those
individuals who did show an improvement, the average gain was
19.7%. In the Placebo group, Applicants found that, of those
individuals who did show an improvement, the average gain was close
to the Control group at 30.8%. In the Test group, Applicants found
that, of those individuals who did show an improvement, the average
gain was more than triple the Control group and double the Placebo
group at 63.8%. This information would indicate that the test
dermal patch was having a beneficial effect on strength endurance.
This improvement is dramatic in that the individuals tested had
only used the test dermal patch for 10 minutes prior to the
test.
[0209] Based on the data collected and the results obtained it was
demonstrated that the invention (i.e., test dermal patch) provides
a method for the improvement of athletic performance, and more
particularly a means by which an individual may increase their net
stamina/strength endurance output. The model utilized to evaluate
the technology was a double-blind placebo controlled study, with 25
college athletes from the Troy State University football team
volunteering to participate in this study. In this evaluation of
strength endurance involving competitive athletes both baseline and
comparative tests were performed prior to any other type of
physical activity.
[0210] It was demonstrated that the group using the invention
(i.e., test dermal patch) showed the highest percentage of
improvement in strength endurance when averaging all members, the
highest percentage of improvement in strength endurance when
averaging only those members who showed an improvement, and the
lowest percentage of decreased performance when averaging only
those individuals who showed a decline in performance.
[0211] While a particular embodiment of the present invention has
been described, it is to be understood that modifications will be
apparent to those skilled in the art without departing from the
spirit of the invention. The scope of the invention, therefore, is
to be determined solely by the following claims.
* * * * *